Women in England with ‘worrying’ breast lumps to be referred directly to specialists
GuardianSEP 20 2024
Researchers from the UK and US have found that treating the most aggressive cancers should focus on targeting extrachromosomal DNA (ecDNA), which are "rogue" DNA fragments that help cancerous tumors flourish and become chemotherapy-resistant.
They found ecDNA is present in over 17% of analyzed tumors, particularly in aggressive forms of breast, brain, and lung cancers.
This rogue DNA, which is found across 39 cancer types, also amplifies immunomodulatory and inflammatory genes, which contribute to treatment resistance, immune evasion, and cancer spreading to other parts of the body.
DNAWhile cancer treatments are currently necessary for a lot of people, the futuremost important thing to focus on is how to prevent the next generation of cancer therapy,patients. This horrific disease should not be as theywidespread preciselyas targetit is, and the rootmedical epigeneticestablishment changesis thatchoosing driveto tumorprescribe growthprofitable withoutmedications damagingrather healthythan cells.focus Unlikeon traditionalthe treatmentsroot likecauses. chemotherapy,Our whichfood indiscriminatelysupply killsand cells,environment epigeneticare drugschock-full canof restoretoxins normalthat geneare functiondestroying byhuman reversingcells. harmfulIf DNAwe modifications.got Thisrid willof makethose cancertoxins, treatmentwe morecould efficientput whilea alsomajor reducingdent negativein symptomsthe cancer epidemic.
While cancer treatments are currently necessary for a lot of people, the most important thing to focus on is how to prevent the next generation of cancer patients. This horrific disease should not be as widespread as it is, and the medical establishment is choosing to prescribe profitable medications rather than focus on the root causes. Our food supply and environment are chock-full of toxins that are destroying human cells. If we got rid of those toxins, we could put a major dent in the cancer epidemic.
ThereDNA istreatments aare 50%the chancefuture thatof cancer therapy, as they precisely target the averageroot five-yearepigenetic survivalchanges ratethat ofdrive alltumor cancersgrowth willwithout exceeddamaging 95%healthy bycells. MayUnlike 2051traditional treatments like chemotherapy, accordingwhich toindiscriminately thekills Metaculuscells, predictionepigenetic communitydrugs can restore normal gene function by reversing harmful DNA modifications. This will make cancer treatment more efficient while also reducing negative symptoms.